Results 231 to 240 of about 131,366 (318)
A Retrospective Study of Invasive Candidiasis in a Tertiary Teaching Hospital. [PDF]
Dave P, Mishra I, Bhatia G.
europepmc +1 more source
First described in 1994, fixed drug eruption (FDE) to fluconazole is uncommon but possibly underdiagnosed. Of these, women with vaginal candidiasis remain the most affected, with on average more than four occurrences prior to diagnosis. We present a case of a 29‐year‐old female who presented after her third episode of an itchy, oedematous, blistering ...
D. S. Sron +5 more
wiley +1 more source
STAT-1 gain-of-function CMC: Remission of Oral Candidiasis during PD-1 Inhibitor Treatment of Oral Cancer. [PDF]
Helweg-Larsen J +4 more
europepmc +1 more source
Clinical Effects of 5-Fluorocytosine Ointment on Cutaneous Candidiasis
Masaru YASUDA +3 more
openalex +2 more sources
Drug‐Induced Fuchs Syndrome With Isolated Oral Involvement: A Rare Case Report
Stevens–Johnson syndrome (SJS) is a rare, potentially life‐threatening mucocutaneous disorder characterized by epidermal necrosis and mucosal bullous lesions involving less than 10% of the total body surface area. The majority of cases are aggravated by delayed hypersensitivity reactions to medications.
Salina Paudel +6 more
wiley +1 more source
Salivary Biomarker Profiles in Pediatric Oral Candidiasis. [PDF]
Flondor AE +4 more
europepmc +1 more source
Introduction Granulomatosis with polyangiitis (GPA), formerly known as Wegener′s granulomatosis, is a rare, systemic small‐vessel vasculitis characterized by necrotizing granulomatous inflammation. It classically affects the upper airway, lungs, and kidneys.
Sarwer Biplob +4 more
wiley +1 more source
Esophagopleural fistula and candidiasis: endoscopic stent management after steroid-induced perforation. [PDF]
Chen Y +6 more
europepmc +1 more source
From high protection to lethal effect: diverse outcomes of immunization against invasive candidiasis with different Candida albicans extracellular vesicles [PDF]
Raquel Martínez‐López +9 more
openalex +1 more source
Scope Human salivary α‐amylase (sAA) is a therapeutic target for various pathological oral conditions. Several studies have reported that different probiotic strains can inhibit α‐amylase in vitro. However, the mechanisms behind remain largely unknown. To explore this topic, we focused on Levilactobacillus brevis (L.
Serena Altamura +7 more
wiley +1 more source

